|
CHOP Part I |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case, Control |
|
|
92% |
|
|
Cataracts Marshfield Implementation |
Cataracts |
Marshfield Clinic Research Foundation |
Case, Control |
|
|
98%, 98% |
99%, 94% |
|
Marshfield CRC Implementation |
Colorectal Cancer (CRC) |
Marshfield Clinic Research Institute |
Case Only |
|
|
|
|
|
Hypothyroidism Northwestern Implementation |
Hypothyroidism |
Northwestern University |
Case, Control |
|
|
98%, 100% |
100%, 100% |
|
Marshfield Implementation |
Pneumonia- VUMC eMERGE v5.1 |
Marshfield Clinic Research Institute |
Case, Control |
|
|
|
|
|
Geisinger Implementation |
Statins and MACE |
Geisinger |
Case, Control |
|
|
|
|
|
T2D Vanderbilt Implementation |
Type 2 Diabetes Mellitus |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
NU breast ca |
Breast Cancer |
Northwestern University |
Case, Control |
|
|
|
|
|
Implementation for NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CCHMC |
Case Only |
|
|
89% |
100% |
|
Columbia CUMC implementation |
Anxiety algorithm |
Columbia University Medical Center |
Case, Control |
|
|
|
|
|
Appendicitis Case 2-MED |
Appendicitis |
Cincinnati Children's Hospital Medical Center |
Case Only |
|
|
90% |
|
|
CHOP Part II- NONRESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
CHOP |
Case Only |
|
|
85% |
|
|
Cataracts Vanderbilt Implementation |
Cataracts |
Vanderbilt University |
Case Only |
|
|
96% |
|
|
KPWA/UW (primary site) implementation |
Colorectal Cancer (CRC) |
Group Health and University of Washington |
Case, Control |
|
|
|
|
|
Vanderbilt Implementation of Heart Failure |
Heart Failure (HF) with Differentiation between Preserved and Reduced Ejection Fraction |
Vanderbilt University |
Case Only |
|
|
|
|
|
Hypothyroidism GHC Implementation |
Hypothyroidism |
Group Health Cooperative |
Case, Control |
|
|
98%, 100% |
|
|
NU eMERGE pneumonia data |
Pneumonia- VUMC eMERGE v5.1 |
Northwestern University |
Case, Control |
|
|
|
|
|
Statins and MACE: request for lipids lab data sep2015 |
Statins and MACE |
GHRI/UW |
Case, Control |
|
|
|
|
|
CHOP NAFLD |
Non-alcoholic fatty liver disease (NALFD) & Alcoholic Fatty Liver Disease (ALD) |
CHOP |
Case Only |
12 |
|
100% |
|
|
Demonstration Project T2D Implementation |
Type 2 Diabetes - Demonstration Project |
Vanderbilt University |
Case, Control |
|
|
100%, 100% |
|
|
Harvard Anxiety |
Anxiety algorithm |
|
Case Only |
|
|
|
|
|
CHOP implementation Case 1 and Controls |
Appendicitis |
CHOP |
Case, Control |
|
|
86%, 100% |
|
|
Mayo clinic hearing loss implementation |
Hearing Loss |
Mayo Clinic |
Case, Control |
|
|
|
|
|
CHOP Part II- RESPONDERS |
Epilepsy/Antiepileptic drug response algorithm |
|
Case Only |
|
|
85% |
|
|
Mayo implementation |
Cardiorespiratory Fitness Algorithm (eMERGE Mayo Network Phenotype) |
Mayo Clinic |
Case Only |
|
|
|
|
